Related Experiment Video
Updated: Nov 7, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk
Luigi Pannone1, Giulio Falasconi1, Lorenzo Cianfanelli1
1Cardiology Department, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Insights
Sudden cardiac death (SCD) risk is high in patients with preserved or mid-range ejection fraction. This review details current risk stratification strategies for identifying patients who need implantable cardioverter-defibrillators (ICDs).
Area of Science:
- Cardiology
- Electrophysiology
- Cardiovascular Medicine
Background:
- Sudden cardiac death (SCD) is a major cause of mortality in coronary artery disease and heart failure with preserved ejection fraction.
- Patients with preserved or mid-range left ventricular ejection fraction (LVEF >35%) experience a higher absolute number of SCDs globally.
- Current guidelines lack specific recommendations for SCD risk reduction in this patient group.
Purpose of the Study:
- To provide a comprehensive overview of current state-of-the-art risk stratification for SCD.
- To identify patients with mid-range or preserved LVEF who may benefit from implantable cardioverter-defibrillator (ICD) implantation.
- To focus on specific etiologies including ischemic cardiomyopathy, heart failure, atrial fibrillation, and myocarditis.
Main Methods:
- Review of existing literature and ongoing advancements in risk stratification techniques.
- Analysis of electrophysiological and imaging modalities for patient identification.
- Focus on evidence-based approaches for SCD prevention.
Main Results:
- Improvements in risk stratification are enhancing the identification of high-risk individuals.
- Electrophysiological and imaging techniques show promise for personalized risk assessment.
- There remains an unmet need for clear guidelines on ICD implantation in this population.
Conclusions:
- Accurate SCD risk stratification is crucial for patients with preserved or mid-range LVEF.
- Advanced techniques are improving the ability to identify candidates for ICD therapy.
- Further research and guideline development are needed to address SCD prevention in this growing patient cohort.
Abstract:
Sudden cardiac death (SCD) is the leading cause of cardiovascular mortality in patients with coronary artery disease without severe systolic dysfunction and in heart failure with preserved ejection fraction. From a global health perspective, while risk may be lower, the absolute number of SCDs in patients with left ventricle ejection fraction >35% is higher than in those with severely reduced left ventricle ejection fraction (defined as ≤35%). Despite these observations and the high amount of available data, to date there are no clear recommendations to reduce the sudden cardiac death burden in the population with mid-range or preserved left ventricle ejection fraction. Ongoing improvements in risk stratification based on electrophysiological and imaging techniques point towards a more precise identification of patients who would benefit from ICD implantation, which is still an unmet need in this subset of patients. The aim of this review is to provide a state-of-the-art approach in sudden cardiac death risk stratification of patients with mid-range and preserved left ventricular ejection fraction and one of the following etiologies: ischemic cardiomyopathy, heart failure, atrial fibrillation or myocarditis.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

